180 related articles for article (PubMed ID: 8435747)
21. Ketamine, but not MK-801, produces antidepressant-like effects in rats responding on a differential-reinforcement-of-low-rate operant schedule.
Hillhouse TM; Porter JH
Behav Pharmacol; 2014 Feb; 25(1):80-91. PubMed ID: 24370559
[TBL] [Abstract][Full Text] [Related]
22. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
Cory-Slechta DA; Pokora MJ; Widzowski DV
Brain Res; 1992 Dec; 598(1-2):162-72. PubMed ID: 1362517
[TBL] [Abstract][Full Text] [Related]
23. Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
Cory-Slechta DA; Widzowski DV
Brain Res; 1991 Jul; 553(1):65-74. PubMed ID: 1681979
[TBL] [Abstract][Full Text] [Related]
24. Contrasting effects of the competitive NMDA antagonist CPP and the non-competitive NMDA antagonist MK 801 on performance of an operant delayed matching to position task in rats.
Cole BJ; Klewer M; Jones GH; Stephens DN
Psychopharmacology (Berl); 1993; 111(4):465-71. PubMed ID: 7870988
[TBL] [Abstract][Full Text] [Related]
25. Presynaptic glutamatergic function in dentate gyrus in vivo is diminished by chronic exposure to inorganic lead.
Lasley SM; Gilbert ME
Brain Res; 1996 Oct; 736(1-2):125-34. PubMed ID: 8930317
[TBL] [Abstract][Full Text] [Related]
26. Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.
Cory-Slechta DA; O'Mara DJ; Brockel BJ
J Pharmacol Exp Ther; 1998 Aug; 286(2):794-805. PubMed ID: 9694936
[TBL] [Abstract][Full Text] [Related]
27. Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats.
Rezvani AH; Levin ED
Eur J Pharmacol; 2003 Mar; 465(1-2):83-90. PubMed ID: 12650836
[TBL] [Abstract][Full Text] [Related]
28. Learning versus performance impairments following regional administration of MK-801 into nucleus accumbens and dorsomedial striatum.
Cory-Slechta DA; O'Mara DJ; Brockel BJ
Behav Brain Res; 1999 Jul; 102(1-2):181-94. PubMed ID: 10403026
[TBL] [Abstract][Full Text] [Related]
29. Novel reinforcement learning paradigm based on response patterning under interval schedules of reinforcement.
Schifani C; Sukhanov I; Dorofeikova M; Bespalov A
Behav Brain Res; 2017 Jul; 331():276-281. PubMed ID: 28457882
[TBL] [Abstract][Full Text] [Related]
30. Lead exposure and dorsomedial striatum mediation of fixed interval schedule-controlled behavior.
Cory-Slechta DA; Brockel BJ; O'Mara DJ
Neurotoxicology; 2002 Sep; 23(3):313-27. PubMed ID: 12387360
[TBL] [Abstract][Full Text] [Related]
31. Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training.
Cory-Slechta DA; Pokora MJ; Fox RA; O'Mara DJ
Neurotoxicology; 1996; 17(2):445-57. PubMed ID: 8856740
[TBL] [Abstract][Full Text] [Related]
32. Acute behavioral effects of MK-801 in rhesus monkeys: assessment using an operant test battery.
Buffalo EA; Gillam MP; Allen RR; Paule MG
Pharmacol Biochem Behav; 1994 Aug; 48(4):935-40. PubMed ID: 7972299
[TBL] [Abstract][Full Text] [Related]
33. Deficits in fixed-interval performance following prenatal and postnatal lead exposure.
Zenick H; Rodriquez W; Ward J; Elkington B
Dev Psychobiol; 1979 Sep; 12(5):509-14. PubMed ID: 488533
[TBL] [Abstract][Full Text] [Related]
34. Effects of MK-801 stereoisomers on schedule-controlled behavior in rats.
Genovese RF; Lu XC
Psychopharmacology (Berl); 1991; 105(4):477-80. PubMed ID: 1771215
[TBL] [Abstract][Full Text] [Related]
35. MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia.
Talpos J; Aerts N; Waddell J; Steckler T
Psychopharmacology (Berl); 2015 Nov; 232(21-22):3911-20. PubMed ID: 25902874
[TBL] [Abstract][Full Text] [Related]
36. Behavioral manifestations of prolonged lead exposure initiated at different stages of the life cycle: I. Schedule-controlled responding.
Cory-Slechta DA; Pokora MJ
Neurotoxicology; 1991; 12(4):745-60. PubMed ID: 1795899
[TBL] [Abstract][Full Text] [Related]
37. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
France CP; Moerschbaecher JM; Woods JH
J Pharmacol Exp Ther; 1991 May; 257(2):727-34. PubMed ID: 2033515
[TBL] [Abstract][Full Text] [Related]
38. Enhanced stimulus sequence-dependent repeated learning in male offspring after prenatal stress alone or in conjunction with lead exposure.
Cory-Slechta DA; Virgolini MB; Liu S; Weston D
Neurotoxicology; 2012 Oct; 33(5):1188-202. PubMed ID: 22796262
[TBL] [Abstract][Full Text] [Related]
39. AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks.
Stephens DN; Cole BJ
Psychopharmacology (Berl); 1996 Aug; 126(3):249-59. PubMed ID: 8876025
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of MK-801, NMDA and scopolamine on rats learning a four-member repeated acquisition paradigm.
Cohn J; Cory-Slechta DA
Behav Pharmacol; 1992 Aug; 3(4):403-413. PubMed ID: 11224143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
